Login
$CORT
$69.22 -$3.72 (5.1%) Live

$CORT 4 SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Swisher Daniel N Jr, Director

Received 1,500 shares by exercise or conversion ($19.7K) · Sold 1,500 shares ($111K)

04 Nov 2026 Form 4: Maduck Sean, See Remarks

Received 11,841 shares by exercise or conversion ($97.9K) · Sold 11,841 shares ($964K) · Received 13,159 shares by exercise or conversion ($109K) · 1 more

04 Nov 2026 Form 4: Vieira Roberto Wandenkolk, President, Oncology

Received 8,333 shares by exercise or conversion ($180K) · Sold 8,333 shares ($674K)

16 Oct 2026 Form 4: Wilson James N, Director

Sold 10,000 shares ($1.15M)

05 Oct 2026 Form 4: Vieira Roberto Wandenkolk, President, Oncology

Received 8,333 shares by exercise or conversion ($180K) · Sold 8,333 shares ($967K)

05 Oct 2026 Form 4: Lyon Joseph Douglas, See Remarks

Received 810 shares by exercise or conversion ($11K) · Sold 810 shares ($93.5K) · Received 9,190 shares by exercise or conversion ($158K) · 1 more

05 Oct 2026 Form 4: Maduck Sean, See Remarks

Received 413 shares by exercise or conversion ($3.42K) · Sold 413 shares ($47.7K) · Received 24,587 shares by exercise or conversion ($203K) · 1 more

05 Oct 2026 Form 4: Gunn Justin Frederick, See Remarks

Granted 100,000 Stock Option (right to buy)

28 Sep 2026 Form 4: Robb Gary Charles, Chief Business Officer

Gave 17,100 shares as a gift · Acquired 10,000 shares (Gift)

18 Sep 2026 Form 4: Vieira Roberto Wandenkolk, President, Oncology

Sold 296 shares ($29.8K)

18 Sep 2026 Form 4: Robb Gary Charles, Chief Business Officer

Received 17,493 shares by exercise or conversion ($145K)

16 Sep 2026 Form 4: Lyon Joseph Douglas, See Remarks

Received 10,000 shares by exercise or conversion ($130K) · Sold 10,000 shares ($1.13M)

16 Sep 2026 Form 4: Wilson James N, Director

Sold 10,000 shares ($1.11M)

03 Sep 2026 Form 4: Guyer William, Chief Development Officer

Received 328 shares as a grant or award

03 Sep 2026 Form 4: Maduck Sean, See Remarks

Received 25,000 shares by exercise or conversion ($207K) · Sold 25,000 shares ($2.86M) · Received 300 shares as a grant or award · 1 more

03 Sep 2026 Form 4: Mokari Atabak, Chief Financial Officer

Received 276 shares as a grant or award · Gave up 102 shares to cover exercise price or tax ($11.6K)

03 Sep 2026 Form 4: Robb Gary Charles, Chief Business Officer

Received 328 shares as a grant or award · Gave up 91 shares to cover exercise price or tax ($10.3K)

03 Sep 2026 Form 4: Vieira Roberto Wandenkolk, President, Oncology

Received 276 shares as a grant or award · Gave up 102 shares to cover exercise price or tax ($11.6K) · Received 58,333 shares by exercise or conversion ($1.26M) · 1 more

03 Sep 2026 Form 4: Lyon Joseph Douglas, See Remarks

Received 260 shares as a grant or award · Gave up 72 shares to cover exercise price or tax ($8.16K)

28 Aug 2026 Form 4: Park Kimberly, Director

Received 30,000 shares by exercise or conversion ($405K) · Gave up 3,315 shares to cover exercise price or tax ($405K) · Sold 26,685 shares ($3.27M)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support